Name | Cancer-Targeting Compound 1 |
---|
Description | Cancer-Targeting Compound 1 is used in the research of hormone-related cancer, extracted from patent WO 2008021331 A2. |
---|---|
Related Catalog | |
In Vitro | Cancer-Targeting Compound 1 is useful for the research of hormone-related conditions including contraception, treating or preventing fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome, or hormone-dependent carcinomas, providing hormone replacement therapy, stimulating food intake or synchronizing estrus[1]. |
References |
[1]. Thomas, Joseph, et al. OXAZOLIDONE DERIVATIVES AS PR MODULATORS. WO 2008021331 A2. |
Molecular Formula | C15H13N3O2S |
---|---|
Molecular Weight | 299.35 |